We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Despite Rebates, Consumers Are Paying Much More for Specialty Drugs, Report Finds
Despite Rebates, Consumers Are Paying Much More for Specialty Drugs, Report Finds
Although specialty drugs make up only a small fraction of the total retail prescriptions filled in the U.S., they accounted for 37.7 percent of retail and mail-order prescription net spending from 2016 to 2017 even with rebates factored in, a new analysis has found.